Literature DB >> 27848185

Pediatric intestinal Behçet disease complicated by myeloid malignancies.

Kiichiro Kanamitsu1, Akira Shimada2, Ritsuo Nishiuchi3, Tomonari Shigemura4, Yozo Nakazawa4, Kenichi Koike4, Yuichi Kodama5, Yuichi Shinkoda5, Yoshifumi Kawano5, Kozo Yasui6, Koji Sasaki7, Ryosuke Kajiwara7, Hirokazu Tsukahara1, Atsushi Manabe8.   

Abstract

Behçet disease (BD) is rarely seen in children. Its clinical manifestations are believed to differ between pediatric and adult patients. The characteristics of BD complicated by myelodysplastic syndrome (MDS) are well established for adult patients; however, because only a few cases of pediatric-onset BD complicated by MDS have been reported, its clinical characteristics remain unknown. We here retrospectively review pediatric-onset BD complicated by myeloid malignancies in Japan, having identified five such patients. All patients were female and had gastrointestinal involvements, but lacked both major features of BD, i.e., uveitis and association with HLA-B51. All patients had advanced MDS or acute myeloid leukemia and received chemotherapy followed by hematopoietic stem cell transplantation. These five cases suggest that intestinal BD and myeloid malignancies have one or more pathophysiological mechanisms in common.

Entities:  

Keywords:  Gastrointestinal involvements; Myeloid malignancies; Pediatric-onset Behçet disease

Mesh:

Substances:

Year:  2016        PMID: 27848185     DOI: 10.1007/s12185-016-2127-7

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  22 in total

1.  Behçet's disease, myelodysplastic syndrome, trisomy 8, gastroenterological involvement--an association.

Authors:  L Eder; M Rozenbaum; N Boulman; E Aayubkhanov; E Wolfovitz; D Zisman; I Rosner
Journal:  Clin Exp Rheumatol       Date:  2005 Jul-Aug       Impact factor: 4.473

2.  TNF polymorphisms in patients with Behçet disease: a meta-analysis.

Authors:  Zahi Touma; Chantal Farra; Ayad Hamdan; Wael Shamseddeen; Imad Uthman; Hala Hourani; Thurayya Arayssi
Journal:  Arch Med Res       Date:  2010-03-24       Impact factor: 2.235

Review 3.  Behcet's disease: from East to West.

Authors:  Fereydoun Davatchi; Farhad Shahram; Cheyda Chams-Davatchi; Hormoz Shams; Abdolhadi Nadji; Massoomeh Akhlaghi; Tahereh Faezi; Zahra Ghodsi; Alireza Faridar; Farima Ashofteh; Bahar Sadeghi Abdollahi
Journal:  Clin Rheumatol       Date:  2010-03-31       Impact factor: 2.980

4.  Preferential suppression of trisomy 8 compared with normal hematopoietic cell growth by autologous lymphocytes in patients with trisomy 8 myelodysplastic syndrome.

Authors:  Elaine M Sloand; Lori Mainwaring; Monika Fuhrer; Shakti Ramkissoon; Antonio M Risitano; Keyvan Keyvanafar; Jun Lu; Atanu Basu; A John Barrett; Neal S Young
Journal:  Blood       Date:  2005-04-12       Impact factor: 22.113

5.  In vitro proliferation and differentiation of erythroid progenitors from patients with myelodysplastic syndromes: evidence for Fas-dependent apoptosis.

Authors:  Yann-Erick Claessens; Didier Bouscary; Jean-Michel Dupont; Françoise Picard; Josiane Melle; Sylvie Gisselbrecht; Catherine Lacombe; François Dreyfus; Patrick Mayeux; Michaëla Fontenay-Roupie
Journal:  Blood       Date:  2002-03-01       Impact factor: 22.113

6.  Cytokine production profile in patients with Behcet's disease treated with infliximab.

Authors:  Midori Misumi; Eri Hagiwara; Mitsuhiro Takeno; Yukiko Takeda; Yuko Inoue; Takashi Tsuji; Atsuhisa Ueda; Satoshi Nakamura; Shigeaki Ohno; Yoshiaki Ishigatsubo
Journal:  Cytokine       Date:  2003-12-07       Impact factor: 3.861

7.  Low serum levels of tumor necrosis factor and interleukin-1 beta in myelodysplastic syndromes responsive to recombinant erythropoietin.

Authors:  P Musto; R Matera; M M Minervini; C Checchia-de Ambrosio; C Bodenizza; A Falcone; M Carotenuto
Journal:  Haematologica       Date:  1994 May-Jun       Impact factor: 9.941

Review 8.  Pediatric myelodysplastic syndromes: they do exist!

Authors:  Taly Glaubach; Lisa J Robinson; Seth J Corey
Journal:  J Pediatr Hematol Oncol       Date:  2014-01       Impact factor: 1.289

9.  Fas antigen expression on CD34+ human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitro.

Authors:  J Maciejewski; C Selleri; S Anderson; N S Young
Journal:  Blood       Date:  1995-06-01       Impact factor: 22.113

10.  Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behçet's disease.

Authors:  Cem Evereklioglu; Hamdi Er; Yusuf Türköz; Mustafa Cekmen
Journal:  Mediators Inflamm       Date:  2002-04       Impact factor: 4.711

View more
  2 in total

1.  Intestinal Behçet disease associated with myelodysplastic syndrome accompanying trisomy 8 successfully treated with abdominal surgery followed by hematopoietic stem cell transplantation: A case report.

Authors:  Tomoyuki Asano; Shuzo Sato; Makiko Yashiro Furuya; Hiroshi Takahashi; Akiko Shichishima-Nakamura; Hiroshi Ohkawara; Tatsuo Fujiwara; Naohiko Gunji; Choichiro Hashimoto; Tomoyuki Momma; Motonobu Saito; Hiroshi Nakano; Guy Watanabe; Jumpei Temmoku; Yuya Fujita; Naoki Matsuoka; Hiroko Kobayashi; Hiroshi Watanabe; Mariko Mouri; Fumi Mashiyama; Hiroko Sakuma; Hiromasa Ohira; Masaaki Mori; Takayuki Ikezoe; Kiyoshi Migita
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

Review 2.  Chromosomal abnormalities related to fever of unknown origin in a Chinese pediatric cohort and literature review.

Authors:  Bijun Sun; Mi Yang; Jia Hou; Wenjie Wang; Wenjing Ying; Xiaoying Hui; Qinhua Zhou; Haili Yao; Jinqiao Sun; Xiaochuan Wang
Journal:  Orphanet J Rare Dis       Date:  2022-07-27       Impact factor: 4.303

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.